ArticleScientific reports2025
Eco-friendly synthesis and biomedical potential of silver nanoparticles using Pandanus dubius extract.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study highlights a novel, eco-friendly approach for synthesizing silver nanoparticles (AgNPs) using the Pandanus dubius extract. This study characterized the resulting Pds-AgNPs and evaluated their antioxidant, antibacterial, and anticancer properties. The characterization of Pds-AgNPs used various methods UV-Vis spectroscopy confirmed the absorption peak at 458 nm, while FT-IR analysis identified the functional groups responsible for reduction and stabilization. X-ray diffraction (XRD) analysis provided insights into the crystallographic features of the nanoparticles, and scanning electron microscopy (SEM) and transmission electron microscopy (TEM) analyses revealed their spherical shape. The biomedical potential of Pds-AgNPs was thoroughly investigated. Antioxidant activity, significant free radical scavenging capabilities, with the Pds-AgNPs outperforming the methanol extract. The antibacterial activity of Pds-AgNPs was tested against human pathogens, and the Pds-AgNPs exhibited strong antibacterial efficacy, surpassing the performance of the methanol extract alone. Furthermore, the anticancer properties of Pds-AgNPs were assessed using in vitro cytotoxicity assays on A549 human lung cancer cells. The IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.